Coronavirus India: On Tuesday morning Prime Minister Narendra Modi held a meeting with all Chief Ministers whose states are seeing a massive surge in coronavirus cases, via video conferencing. Modi said, “No one can impose any view, and all have to work together.” PM Modi has cautioned states not to allow any laxity in following ...

Oxford vaccine: By late January or early February, India is most likely to get the first lot of Covid-19 vaccines that will be used for frontline workers, including healthcare personnel and municipal staff. The Oxford-AstraZeneca vaccine’s availability will be possible as the Pune based Serum Institute of India is to get the approval for vaccine’s ...

India’s vaccination strategy: As the number of Coronavirus cases continues to surge across various states in India, Prime Minister Narendra Modi on Friday held a virtual meeting with top officials to review the vaccination strategy of the country and efforts needed to make the vaccine accessible to the public. Taking to Twitter, PM Modi stated ...

Covid-19 Vaccine tracking: With Pfizer-BioNTech and Moderna vaccine announcing their high efficacy results, the wait seems to be shorter for the Covid-19 vaccine. In line with this, the airline operators and airports in India have started preparing for the herculean task that lays ahead of them – vaccine transportation and distribution across the country.  Pfizer-BioNtech ...

Phase III clinical trials: Hyderabad based pharma giant, Bharat Biotech has announced of beginning phase III clinical trials of India’s first indigenous Covid-19 vaccine, COVAXIN. This phase will include 26,000 volunteers across 25 centres in India and is to be conducted in collaboration with the ICMR (Indian Council of Medical Research). This will make COVAXIN ...

Common people will have to wait till 2022 to get a shot of the coronavirus vaccine, confirms the AIIMS director Randeep Guleria.  In an interview to CNN-News18, the director who is also a part of the National Task Force designated to handle the coronavirus crisis in the country said  it will take “more than a ...

A highly anticipated Covid-19 vaccine, COVAXIN, is being developed by Hyderabad-based Bharat Biotech in collaboration with ICMR (Indian Council of Medical Research). ICMR officials have said that the vaccine that was earlier being projected to launch only be second quarter of 2021, can now be hoped to be launched as early as February.  This is ...

Tamil Nadu Chief Minister Edappadi K. Palaniswami on Thursday announced free COVID-19 vaccine for everyone in the state once it is approved for mass production, hours after the Bharatiya Janata Party (BJP) promised free Coronavirus vaccination for all in Bihar in its election manifesto ahead of the upcoming assembly polls. Palaniswami’s promise for free COVID-19 ...

Amid the ongoing efforts to combat the novel Coronavirus pandemic in the country, the Indian Council of Medical Research (ICMR) on Tuesday said that a person can get reinfected with COVID-19 if antibodies against the virus reduce in their body within five months after recovering from the disease. In line with this development, ICMR Director-General ...

 Intranasal vaccine for Covid-19 virus SARS-CoV-2 is not under any clinical trial currently, but Serum Institute of India has started production of an intranasal vaccine candidate, informed Union Health Minister Dr. Harsh Vardhan on Monday. Various Covid-19 vaccine candidates are currently under human trials in India. Dr. Harsh Vardhan said, “Flumist nasal spray is a ...